Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Syeda Nadia Nadeem

University of Liverpool Medical School, UK

Title: A New Era in Acute Ischaemic Stroke Treatment: A Review of UK and European Thrombectomy Guidelines.

Biography

Biography: Syeda Nadia Nadeem

Abstract

Background: Acute ischaemic stroke is the second leading cause of death worldwide. It creates a massive burden not only on the patients’ life but society as a whole. There has been many advancement in stroke management over the past few decades but 2015 has shown giant leaps in this. Up till now, thrombolysis was the main stroke treatment but recently several randomised controlled trials have emerged to demonstrate the efficacy behind using thrombectomy and how it will lead us into the future by treating ischaemic stroke quicker and more effectively than ever before. Aim: To perform a systematic review of the new trials, which compare thrombectomy to best medical care. Furthermore, to critically analyse the current thrombectomy guidelines across UK and Europe in order to develop a thrombectomy best practice protocol, which can be used as a guide worldwide. Method: Numerous articles which highlight the use of thrombectomy compared to thrombolysis alone in acute ischemic stroke were reviewed. Most recent UK and Europe guidelines for thrombectomy use were compared and critically appraised. Results and Conclusion: Results show that thrombectomy used with thrombolysis reduces mortality rates, and improves patients’ functional independence and vessel reperfusion rates significantly from 37% to 100% compared to thrombolysis alone. Current European recommendations complies with these results and forms relevant guidance, whereas, the UKs guidelines are incompatible, lacking structure and recent evidence. As a result, this review has created a new protocol which encompasses the trial results and European recommendations, in the hope to assist physicians worldwide.